Related posts
DUBLIN, November 28, 2022 /PRNewswire/ — The report “Immuno-Oncology Market: Global Industry Analysis, Trends, Market Size and Forecast to 2028” has been added to from ResearchAndMarkets.com offer.
The global immuno-oncology market report provides qualitative and quantitative analysis for the period 2022 to 2028. The report forecasts the global immuno-oncology market to grow with a CAGR of almost 18% over the forecast period from 2022 to 2028. The study on the immuno-oncology market covers the analysis of major geographies such as North America, Europe, Asia Pacificand right-of-way for the period from 2022 to 2028.
The Immuno-Oncology Market report is a comprehensive study and presentation of the global immuno-oncology market drivers, restraints, opportunities, demand factors, market size, forecast and trends. -oncology over the period 2022 to 2028. In addition, the report is a collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insight into the competitive rivalry, market vendor and buyer positions, and opportunities for new entrants in the global immuno-oncology market over the period of 2022 to 2028. In addition, Growth Matrix has given in the report provides insight into investment areas that existing or new market players can consider.
Report results
1) Drivers
- Increase in research and development in the field of cancer immunotherapy will drive the growth of the market
- Increasing usage in developed countries will drive the growth of the market.
2) Constraints
- High costs compared to chemotherapy and radiotherapy will hamper the growth of the market.
3) Opportunities
- The introduction of innovative and advanced treatment options creates new opportunities for growth.
What does this report bring?
1. Comprehensive analysis of global and regional markets of Immuno-Oncology Market.
2. Comprehensive coverage of all segments of the Immuno-Oncology market to analyze trends, global market developments and market size forecast till 2028.
3. Comprehensive analysis of the companies operating in the global Immuno-Oncology Market. The company profile includes product portfolio analysis, revenue, SWOT analysis and latest company developments.
4. Growth Matrix presents an analysis of product segments and geographies that market players should focus on to invest, consolidate, grow and/or diversify.
Main topics covered:
1. Preface
2. Executive Summary
3. Global Immuno-Oncology Market Overview
3.1. Introduction
3.2. Market dynamics
3.2.1. Drivers
3.2.2. Constraints
3.2.3. Opportunities
3.3. Analysis of the impact of COVID-19 on the immuno-oncology market
3.4. Porter’s Five Forces Analysis
3.5. Growth matrix analysis
3.5.1. Growth Matrix Analysis by Type
3.5.2. Analysis of the growth matrix by targets
3.5.3. Growth matrix analysis by indication
3.5.4. Analysis of the growth matrix by end users
3.5.5. Growth Matrix Analysis by Region
3.6. Immuno-Oncology Market Value Chain Analysis
4. Immuno-Oncology Market Macro Indicators Analysis
5. Global Immuno-Oncology Market by Type
5.1. Immune cell therapy
5.2. Monoclonal antibodies
5.3. Checkpoint Inhibitors
5.4. Cytokines
5.5. Cancer vaccines
5.6. Others
6. Global Immuno-Oncology Market by Target
6.1. GAL-3
6.2. Anti-CTLA-4
6.3. MAGE-A3
6.4. VEGF
6.5. HDACs
6.6. Others
7. Global Immuno-Oncology Market by Indication
7.1. Malignant tumors
7.2. Benign tumors
7.3. Others
8. Global Immuno-Oncology Market by End Users
8.1. Hospitals
8.2. Specialized clinics
8.3. Others
9. Global Immuno-Oncology Market by Region 2022-2028
10. Company Profiles and Competitive Landscape
10.1. Competitive landscape in the global immuno-oncology market
10.2. Profiled companies
10.2.1. Bristol Myers Squibb Company
10.2.2. Novartis AG
10.2.3. F. Hoffmann-LA Roche Ltd.
10.2.4. Merck & Co., Inc.
10.2.5. Regeneron Pharmaceuticals
10.2.6. GlaxoSmithKline Plc.
10.2.7. Eli Lilly and company
10.2.8. Fresenius Kabi AG
10.2.9. Pfizer Inc.
10.2.10. AstraZeneca PLC
For more information about this report visit https://www.researchandmarkets.com/r/1jeptq
Media Contact:
Research and Markets
Laura Woodsenior
[email protected]
For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900
US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
